EyePoint, Inc. (EYPT)
0.3099
-0.01
(-3.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.3099
0.00 (0.00%)
After-Hours: 19:59
EyePoint Enterprise Value : -71.94M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | -71.94M |
| November 11, 2026 | -68.78M |
| November 10, 2026 | -64.75M |
| November 09, 2026 | -68.33M |
| November 06, 2026 | -68.50M |
| November 05, 2026 | -68.84M |
| November 04, 2026 | -65.52M |
| November 03, 2026 | -65.10M |
| November 02, 2026 | -67.24M |
| October 30, 2026 | -69.48M |
| October 29, 2026 | -66.80M |
| October 28, 2026 | -67.02M |
| October 27, 2026 | -68.22M |
| October 26, 2026 | -68.01M |
| October 23, 2026 | -64.71M |
| October 22, 2026 | -62.71M |
| October 21, 2026 | -62.55M |
| October 20, 2026 | -64.65M |
| October 19, 2026 | -61.70M |
| October 16, 2026 | 155.01M |
| October 15, 2026 | 167.75M |
| October 14, 2026 | 156.71M |
| October 13, 2026 | 161.81M |
| October 12, 2026 | 183.05M |
| October 09, 2026 | 189.85M |
| Date | Value |
|---|---|
| October 08, 2026 | 194.95M |
| October 07, 2026 | 183.05M |
| October 06, 2026 | 170.30M |
| October 05, 2026 | 168.60M |
| October 02, 2026 | 177.10M |
| October 01, 2026 | 175.40M |
| September 30, 2026 | 178.80M |
| September 29, 2026 | 132.53M |
| September 28, 2026 | 123.18M |
| September 25, 2026 | 149.53M |
| September 24, 2026 | 152.08M |
| September 23, 2026 | 158.03M |
| September 22, 2026 | 187.77M |
| September 21, 2026 | 183.52M |
| September 18, 2026 | 169.07M |
| September 17, 2026 | 180.97M |
| September 16, 2026 | 135.08M |
| September 15, 2026 | 152.93M |
| September 14, 2026 | 203.07M |
| September 11, 2026 | 201.37M |
| September 10, 2026 | 203.07M |
| September 09, 2026 | 210.72M |
| September 08, 2026 | 229.41M |
| September 04, 2026 | 231.11M |
| September 03, 2026 | 229.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ocular Therapeutix, Inc. | 930.28M |
| Regeneron Pharmaceuticals, Inc. | 91.75B |
| Corcept Therapeutics, Inc. | 7.700B |
| Eli Lilly & Co. | 1.388T |
| Hyperion DeFi, Inc. | 40.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -95.61M |
| Revenue (Quarterly) | 0.756M |
| Total Expenses (Quarterly) | 96.37M |
| EPS Diluted (Quarterly) | -1.071 |
| Gross Profit Margin (Quarterly) | 30.82% |
| Profit Margin (Quarterly) | -12.65K% |
| Earnings Yield | -1.28K% |
| Normalized Earnings Yield | -1278.99 |